July 10th 2024
Research shows an increased risk for suicidal thoughts, suicide attempts, and even death by suicide following brain injury.
Southern California Psychiatry Conference
September 13-14, 2024
Register Now!
Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder
View More
PER® Psychiatry Summit
November 7, 2024
View More
5th Annual International Congress on the Future of Neurology®
View More
2023 Annual Psychiatric Times™ World CME Conference
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Real Psychiatry 2025
January 17 - 18, 2025
View More
More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression
View More
Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans
View More
Expert Perspectives in the Recognition and Management of Postpartum Depression
View More
Mental Representations and Unilateral Neglect: A Revealing Clinical Study
June 24th 2015We are a long way from understanding the complex neural basis for behaviors such as mentalization. But, we can mentally imagine the scientific pursuit of questions, one after another, that might get us to that goal.
Read More
Management of Mild Traumatic Brain Injury
February 27th 2015A considerable overlap exists between TBI and disorders in cognition, behavior, and personality, which can provide even greater clinical challenges. More than 70% of the cases of TBI are mild, which makes this subgroup of particular clinical interest.
Read More
Transcranial Magnetic Stimulation in Neuropsychiatry: An Update
February 27th 2015The potential of TMS as a treatment for cognitive disorders, fatigue, pain, and other manifestations of brain disease is discussed, as is the encouraging prospect for neuropsychiatric management of many patients.
Read More
Brain Stimulation With ECT: Neuroscience Insights From an Old Treatment
January 22nd 2015Some recent breakthroughs, using newly developed neuroscience investigational tools, suggest that if research resources are available, we could soon make substantial advances in understanding the mechanism of action of ECT.
Read More
Brief Psychotherapy at the Bedside: Existential Neuroscience to Mobilize Assertive Coping
November 28th 2014For severely ill patients, understanding the neurobiological underpinning of assertive coping provides an additional map for rapid assessment, formulation, and intervention to bolster assertive coping.
Read More
New Federal BRAIN Research Discoveries Are Targeted to Improve Clinical Practice
November 17th 2014Although the early focus of the NIH component of the BRAIN Initiative is on tool development, the examples listed in this article show that these tools will have relevance to practicing clinicians within the lifetime of the Initiative.
Read More
The Most Exciting Time in the History of Psychiatry
October 15th 2014Advances in psychiatric research, spanning the entire spectrum of biological, psychological, and social aspects of mental processes and functions, have transformed the field of psychiatry. More in this inaugural piece by Psychiatric Times' Editor in Chief.
Read More
Ketamine for Treatment-Resistant Unipolar Depression: Current Evidence
September 30th 2014The discovery that a single IV infusion of low-dose (subanesthetic) ketamine exerts rapid antidepressant effects constitutes an expansion in our understanding of the neurobiology of depression and provides new avenues for drug development.
Read More
Neurostimulation for Mood Disorders
September 5th 2014We have medications that can affect serotonin, norepinephrine, and-to a lesser extent-dopamine. Many other neurotransmitters are involved with mood disorders, but we have no medications yet to target them. Neurostimulation offers a non-systemic somatic approach to depression, often with an improved side effect profile. More in this Q&A.
Read More
The Monoaminergic System and Its Putative Role in Alzheimer Disease
August 14th 2014The SSRIs, although principally targeting serotonin transporter, are complex drugs that might work on other neurotransmitter and receptor systems. It is likely worthwhile to look at the effects of other monoamine and neuropeptide systems on the enzymatic machinery cleaving the amyloid precursor protein.
Read More